Skip to main content
Retour
Watch Compare

Microbot Medical Inc.

Qualité des données : 83%
MBOT
NASDAQ Manufacturing Measuring & Analyzing Instruments
2,39 €
▼ 0,04 € (-1,65%)
6 months return
—
Momentum
Neutral
ROE
-24,21%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-24,21%
Au-dessus de la moyenne du secteur (-54,68%)
ROIC-21,33%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio27,53
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-12,44 | -7,85
En dessous de la moyenne du secteur (-1,49)
P/B Ratio2,09
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -13,11 M

Price History

Tendances Financières

Objectif de Cours des Analystes

3 analystes
Buy
+213.8%
upside to target
Actuel
2,39 €
Consensus Target
7,50 €
5,00 €
Bas
12,00 €
Haut
Prévisions
P/E Prévisionnel
-7,85
BPA Prévisionnel
-0,33 €
CA Est.
9,46 M

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,07 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,08 € -0,10 € -0,07 € -0,04 € — —
Estimate -0,13 € -0,08 € -0,06 € -0,06 € -0,07 € -0,08 €
Surprise +38,46% -25,00% -16,67% +33,33% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -24,21% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -13,14 M
ROE -24,21% ROA -22,88%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -13,11 M
ROIC -21,33% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 27,53
Debt / Equity N/A Current Ratio 27,53
Interest Coverage N/A Asset Turnover N/A
Working Capital 77,85 M Tangible Book Value 78,22 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -12,44 · EV/EBITDA: N/A
P/E Ratio -12,44 Forward P/E -7,85
P/B Ratio 2,09 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 17,28 Fwd Earnings Yield N/A
FCF Yield -8,01%
Market Cap 163,53 M Enterprise Value 156,83 M

Per Share

EPS: -0,29 · FCF/Share: -0,20
EPS (Diluted TTM) -0,29 Revenue / Share N/A
FCF / Share -0,20 OCF / Share -0,19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 99,73% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 99,73%
SBC-Adj. FCF -14,21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -13,14 M -11,44 M -10,74 M -13,17 M -11,31 M
EPS (Diluted) -0,29 -0,73 -1,05 — —
Gross Profit — — — — —
Operating Income -14,74 M -11,63 M -9,86 M -13,28 M -11,36 M
EBITDA — — — — —
R&D Expenses 6,28 M 6,63 M 5,72 M 7,74 M 6,15 M
SG&A Expenses 8,46 M — — — —
D&A 47 000,0 91 000,0 106 000,0 102 000,0 76 000,0
Interest Expense — — — — —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 81,54 M 6,03 M 8,33 M 9,54 M 16,77 M
Total Liabilities 3,99 M 2,50 M 3,83 M 2,25 M 2,39 M
Shareholders' Equity 77,55 M 3,53 M 4,50 M 7,29 M 14,38 M
Total Debt — — — — —
Cash & Equivalents 3,91 M 3,11 M 2,47 M 2,44 M 13,49 M
Current Assets 79,82 M 5,82 M 7,92 M 8,81 M 15,88 M
Current Liabilities 3,42 M 2,46 M 3,79 M 2,07 M 1,98 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -12,4 -1,5
P/B 2,1 1,6
ROE % -24,2 -54,7
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock
BRUSX BRUSX
0,25% weight